Strategic Planning Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-613
Closed -$249K 86
2025
Q2
$249K Sell
613
-7,316
-92% -$3.06M 0.04% 74
2025
Q1
$3.95M Buy
7,929
+1,314
+20% +$712K 0.77% 49
2024
Q4
$3.44M Buy
6,615
+286
+5% +$157K 0.63% 53
2024
Q3
$3.92M Buy
6,329
+343
+6% +$203K 0.77% 46
2024
Q2
$3.31M Buy
5,986
+1,279
+27% +$733K 0.72% 49
2024
Q1
$2.74M Buy
4,707
+617
+15% +$346K 0.68% 46
2023
Q4
$2.17M Buy
+4,090
New +$1.98M 0.72% 47

Other funds holding TMO

Strategic Planning Group's TMO Position: Q3 2025 in Review

Strategic Planning Group sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 613 shares — an estimated $249K sold.

Strategic Planning Group first reported a position in TMO in Q4 2023 and held it in 7 quarters. The position peaked at $3.95M in Q1 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Strategic Planning Group reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Strategic Planning Group sold 613 Thermo Fisher Scientific shares in Q3 2025, an estimated $249K.
  • Strategic Planning Group first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 7 quarters.
  • Strategic Planning Group's Thermo Fisher Scientific position peaked at $3.95M in Q1 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Strategic Planning Group's 13F filing for Q3 2025, filed 23 Oct 2025.